相似文献
1
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).
Pharmacogenet Genomics. 2011 Mar;21(3):152-61. doi: 10.1097/FPC.0b013e3283385a1c.
2
Multidrug resistance in epilepsy: a pharmacogenomic update.
Expert Opin Pharmacother. 2007 Jul;8(10):1441-9. doi: 10.1517/14656566.8.10.1441.
3
The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs.
Pharmacol Rep. 2012;64(5):1011-9. doi: 10.1016/s1734-1140(12)70900-3.
4
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Xenobiotica. 2008 Jul;38(7-8):802-32. doi: 10.1080/00498250701867889.
5
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499.
6
Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Biochem Pharmacol. 2009 Aug 15;78(4):355-64. doi: 10.1016/j.bcp.2009.04.023. Epub 2009 May 3.
7
Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Anticancer Agents Med Chem. 2010 Oct 1;10(8):582. doi: 10.2174/187152010794473993.
8
Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1.
Biochemistry. 2009 Jul 7;48(26):6249-58. doi: 10.1021/bi900373x.
9
Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Biochem Cell Biol. 2006 Dec;84(6):979-92. doi: 10.1139/o06-199.
10
Clinical significance of ABCB1 genotyping in oncology.
J Oncol Pharm Pract. 2010 Mar;16(1):39-44. doi: 10.1177/1078155209104380. Epub 2009 Apr 28.
引用本文的文献
1
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.
J Pers Med. 2025 Aug 18;15(8):386. doi: 10.3390/jpm15080386.
2
Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection.
Pharmaceutics. 2025 Jun 26;17(7):832. doi: 10.3390/pharmaceutics17070832.
3
Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive review.
Future Sci OA. 2025 Dec;11(1):2528490. doi: 10.1080/20565623.2025.2528490. Epub 2025 Jul 16.
4
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.
Exp Mol Med. 2025 Jun 30. doi: 10.1038/s12276-025-01466-5.
5
A Systematic Review of ABCB1 Polymorphisms and Antiseizure Medication Resistance: Insights from Effect Size and Study Power Analysis.
Int J Mol Sci. 2025 Jun 10;26(12):5548. doi: 10.3390/ijms26125548.
6
Glucocorticoid-induced osteoporosis in children: emerging vascular and molecular targets.
Curr Opin Pediatr. 2025 Aug 1;37(4):390-397. doi: 10.1097/MOP.0000000000001476. Epub 2025 Jun 2.
7
Genome-wide association study of direct oral anticoagulants and their relation to bleeding.
Eur J Clin Pharmacol. 2025 May;81(5):771-783. doi: 10.1007/s00228-025-03821-x. Epub 2025 Mar 21.
8
Computational studies on the functional and structural impact of pathogenic mutations in enzymes.
Protein Sci. 2025 Apr;34(4):e70081. doi: 10.1002/pro.70081.
9
Polymorphism Is Associated with Higher Carbamazepine Clearance in Children.
Pediatr Rep. 2025 Jan 16;17(1):10. doi: 10.3390/pediatric17010010.
10
Structural insights into binding-site access and ligand recognition by human ABCB1.
EMBO J. 2025 Feb;44(4):991-1006. doi: 10.1038/s44318-025-00361-z. Epub 2025 Jan 13.
本文引用的文献
1
Immunosuppressors as multidrug resistance reversal agents.
Methods Mol Biol. 2010;596:433-46. doi: 10.1007/978-1-60761-416-6_19.
2
Identification of novel substrates for human cytochrome P450 2J2.
Drug Metab Dispos. 2010 Feb;38(2):347-56. doi: 10.1124/dmd.109.030270. Epub 2009 Nov 18.
3
Expression and induction of p-glycoprotein-1 on cultured human brain endothelium.
J Cereb Blood Flow Metab. 2009 Nov;29(11):1760-3. doi: 10.1038/jcbfm.2009.101. Epub 2009 Jul 29.
4
Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population.
Drug Metab Pharmacokinet. 2009;24(3):255-60. doi: 10.2133/dmpk.24.255.
5
Dietary regulation of P-gp function and expression.
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):789-801. doi: 10.1517/17425250902997967.
6
The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells.
Acta Pharmacol Sin. 2009 Jul;30(7):956-64. doi: 10.1038/aps.2009.85. Epub 2009 Jun 22.
7
Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
Drug Metab Dispos. 2009 Aug;37(8):1604-10. doi: 10.1124/dmd.109.027219. Epub 2009 May 21.
8
Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes.
Clin Cancer Res. 2009 Jun 1;15(11):3705-15. doi: 10.1158/1078-0432.CCR-08-2048. Epub 2009 May 19.
9
Influx and efflux transport as determinants of melphalan cytotoxicity: Resistance to melphalan in MDR1 overexpressing tumor cell lines.
Biochem Pharmacol. 2009 Jul 1;78(1):45-53. doi: 10.1016/j.bcp.2009.03.026. Epub 2009 Apr 5.
10
Ivermectin toxicosis in dogs: a retrospective study.
J Am Anim Hosp Assoc. 2009 May-Jun;45(3):106-11. doi: 10.5326/0450106.
Zotero 插件